International Stem Cell Corporation Announces Positive Results of Primate Parkinson's Study

International Stem Cell Corporation a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells announced today safety and encouraging efficacy of stem cell therapy in rodent and non-human primate models of Parkinson's disease.

http://www.biospace.com/news_story.aspx?StoryID=290936&full=1